Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials

Eugenio Maria Mercuri, Marika Pane, Elena Stacy Mazzone, Maria Carmela Pera, Adele D'Amico, Serena Sivo, Enrico Silvio Bertini, Richard Finkel, Jacqueline Montes, Maria Pia Sormani, Marion Main, Danielle Ramsey, Anna Mayhew, Allan M. Glanzman, Sally Dunaway, Rachel Salazar, Amy Pasternak, Janet Quigley, Mariacristina Scoto, Sonia MessinaMaria Sframeli, Gian Luca Vita, Marleen Van Den Hauwe, Nathalie Goemans, Petra Kaufmann, Basil T. Darras, Enrico Bertini, Francesco Muntoni, Darryl C. De Vivo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

76 Citazioni (Scopus)


The aim of the study was to establish 12-month changes in the Hammersmith Functional motor scale in a large cohort of SMA patients, to identify patterns of disease progression and the effect of different variables. 268 patients were included in this multicentric study. Their age ranged between 2.5 and 55.5 years at baseline, 68 were ambulant and 200 non-ambulant. The baseline scores ranged between 0 and 66 (mean 23.91, SD 20.09). The 12-month change was between -14 and +9 (mean -0.56, SD 2.72). Of the 268 patients, 206 (76.86%) had changes between -2 and +2 points. Ambulant and non-ambulant subjects had a different relationship between baseline values and age (p for age X ambulation interaction = 0.007). There was no association with age in ambulant subjects, while there was a significant heterogeneity at different age for non-ambulant patients (p < 0.001). The 12-month change (adjusted for baseline) was not associated with age in ambulant patients (p = 0.34), but it was significantly different among various age groups in non-ambulant patients. Our results suggest that there are different profiles of progression in ambulant and non-ambulant patients, and that age may play an important role in the progression of non-ambulant patients.
Lingua originaleEnglish
pagine (da-a)126-131
Numero di pagine6
RivistaNeuromuscular Disorders
Stato di pubblicazionePubblicato - 2016


  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Disease Progression
  • Female
  • Genetics (clinical)
  • Hammersmith Functional Motor Scale
  • Humans
  • Male
  • Middle Aged
  • Mobility Limitation
  • Neurology
  • Neurology (clinical)
  • Outcome measures
  • Pediatrics, Perinatology and Child Health
  • Retrospective Studies
  • Spinal Muscular Atrophies of Childhood
  • Spinal muscular atrophy
  • Young Adult


Entra nei temi di ricerca di 'Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials'. Insieme formano una fingerprint unica.

Cita questo